Publicacións (9) Publicacións de Alejandro Rodríguez Vilela

2022

  1. Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 242-250

  2. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

2021

  1. Economic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1055-1062

2020

  1. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals

    European Journal of Medical Genetics, Vol. 63, Núm. 12

2019

  1. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 10

2018

  1. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467

2010

  1. Prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de hemodinámica en pacientes con sospecha de infarto de miocardio con elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 63, Núm. 5, pp. 518-527

  2. Prognostic value of exercise echocardiography in patients with atrial fibrillation

    European Journal of Echocardiography, Vol. 11, Núm. 4, pp. 346-351

2009

  1. Impending rupture of a giant ascending aortic aneurysm

    Cardiology Journal, Vol. 16, Núm. 1, pp. 84-85